Literature DB >> 10831893

Retreatment after initial laser in situ keratomileusis.

W A Lyle1, G J Jin.   

Abstract

PURPOSE: To report the results of laser in situ keratomileusis (LASIK) retreatment in patients with primary undercorrection and with postoperative regression and to assess the efficacy and safety of LASIK retreatment.
SETTING: The Eye Institute of Utah, Salt Lake City, Utah, USA.
METHODS: The prospective study included 157 eyes of 108 patients. Using the VISX Star laser, retreatments were performed for undercorrection in 43 eyes (27%) and for regression in 114 eyes (73%). The mean follow-up was 15 months (range 6 to 28 months) after the initial surgery and 10 months (range 3 to 25 months) after the repeat LASIK procedure.
RESULTS: Overall, the mean spherical equivalent (SE) was -6.11 +/- 2.35 diopters (D) (range -1.87 to -15.00 D) before LASIK and -1.28 +/- 0.57 D (range -0.50 to -3.25 D) prior to retreatment. At the last visit, it was -0.23 +/- 0.41 D (range -2.55 to 1.13 D). One hundred fifty-three eyes (97.5%) were within +/-1.00 D of emmetropia and 128 (81.5%), within +/-0.50 D. The uncorrected visual acuity was 20/20 or better in 68.8% of eyes and 20/40 or better in 98.1%. In all eyes, the best corrected visual acuity (BCVA) improved or remained within 1 line of the pre-revision level. However, 2 eyes (1.3%) lost 2 or more lines of pre-initial LASIK BCVA. Both eyes had a preoperative SE greater than -8.00 D; corneal irregularity was the cause of the decrease in vision.
CONCLUSIONS: Several conclusions can be drawn from this study. First, LASIK retreatment is effective and safe for correcting undercorrection and regression after initial LASIK, and a good visual outcome is expected. Second, in most eyes, regression occurs within 6 months after the initial LASIK. However, regression can develop up to 2 years after LASIK. Third, multiple retreatments will be required in some patients. The outcome in these cases is promising.

Entities:  

Mesh:

Year:  2000        PMID: 10831893     DOI: 10.1016/s0886-3350(00)00319-9

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  8 in total

1.  Analysis of changes in crystalline lens thickness and its refractive power after laser in situ keratomileusis.

Authors:  Liang Wang; Hai-Ke Guo; Jing Zeng; Hai-Ying Jin
Journal:  Int J Ophthalmol       Date:  2012-02-18       Impact factor: 1.779

2.  Visual outcomes of topography-guided excimer laser surgery for treatment of patients with irregular astigmatism.

Authors:  Mohammad Ghoreishi; Afsaneh Naderi Beni; Zahra Naderi Beni
Journal:  Lasers Med Sci       Date:  2013-02-24       Impact factor: 3.161

3.  Analysis of the visual and refractive outcome following laser in situ keratomileusis (LASIK) retreatment over a four-year follow-up period.

Authors:  Ayman Saeed; Maeve O'Doherty; John O'Doherty; Michael O'Keefe
Journal:  Int Ophthalmol       Date:  2007-03-24       Impact factor: 2.029

4.  Integrating binocular vision assessment in refractive surgery work-up: Proposition and protocol.

Authors:  Sumitha Muthu; Jitendra Jethani; Sriram Annavajjhala; Sneha Gupta; Krati Gupta; Pooja Khamar
Journal:  Indian J Ophthalmol       Date:  2020-12       Impact factor: 1.848

5.  Results of laser enhancement for residual myopia after primary laser in situ keratomileusis.

Authors:  Mahfouth A Bamashmus; Hisham A Al-Akhlee; Yasmin A Al-Azani; Najeeb A Al-Kershy
Journal:  Taiwan J Ophthalmol       Date:  2019-11-07

6.  Survival analysis of myopic regression after small incision lenticule extraction and femtosecond laser-assisted laser in situ keratomileusis for low to moderate myopia.

Authors:  Jihong Zhou; Wei Gu; Yan Gao; Wenjuan Wang; Fengju Zhang
Journal:  Eye Vis (Lond)       Date:  2022-08-01

Review 7.  Efficacy and Safety of Topical Timolol Eye Drops in the Treatment of Myopic Regression after Laser In Situ Keratomileusis: A Systematic Review and Meta-Analysis.

Authors:  Xiaochen Wang; Guiqiu Zhao; Jing Lin; Nan Jiang; Qian Wang; Qiang Xu
Journal:  J Ophthalmol       Date:  2015-12-21       Impact factor: 1.909

8.  Reversal of Myopic Correction for Patients Intolerant to LASIK.

Authors:  Amr A Gab-Alla
Journal:  J Ophthalmol       Date:  2021-12-15       Impact factor: 1.909

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.